U.S. market Open. Closes in 2 hours 15 minutes

GOSS | Gossamer Bio, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
RevenueN/AN/AN/AN/AN/AN/AN/AN/A
Cost of Revenue4.38M4.43M5.17M4.27M3.09M297.00KN/AN/A
Gross Profit-4.38M-4.43M-5.17M-4.27M-3.09M-297.00KN/AN/A
Operating Expenses183.76M218.53M216.05M210.58M182.54M99.33M1.15M83.00K
Selling, General & Admin38.45M47.61M45.78M49.73M39.14M44.05M262.00K83.00K
Research & Development145.30M170.92M170.27M160.85M143.40M55.28M891.00KN/A
Other Operating ExpensesN/A1.51M799.00K-174.00K5.83M316.00KN/AN/A
Operating Income-183.76M-218.59M-216.12M-233.96M-186.14M-148.99M-6.65M-83.00K
Other Expenses / Income3.94M-10.79M-17.88M-9.40M5.83M2.02M-118.00KN/A
Before Tax Income-179.82M-229.38M-234.00M-243.36M-180.31M-146.97M-6.77M-83.00K
Income Tax ExpensesN/A10.85M15.07M8.22M511.00K2.04M-5.38M-83.00K
Net Income-179.82M-240.23M-249.08M-251.58M-180.82M-146.97M-6.77M-83.00K
Interest Expenses13.51M13.88M19.44M12.67MN/A12.00K118.00KN/A
Basic Shares Outstanding152.62M84.57M74.84M68.51M54.74M60.40M24.83M24.83M
Diluted Shares Outstanding152.62M84.57M74.84M68.51M54.74M60.40M24.83M24.83M
EBITDA-172.15M-211.07M-209.32M-233.96M-186.14M-148.99M-6.65M-83.00K
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-166.31M-215.50M-214.56M-230.69M-180.31M-144.92M-12.04M-166.00K
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙